Tuesday, 10 December 2019

Pharma News

  • GSK extends Genpact's finance contract by 5 years

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: Genpact, a global leader in business process management and technology services, has been awarded a five-year contract extension by global pharmaceutical leader GlaxoSmithKline (...Read more

  • Otsuka launches English website for global viewers

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Japan-based Otsuka Pharmaceutical launched a newly designed English corporate website in collaboration with an Amsterdam-based creative agency. The new site reflects Otsuka's phi...Read more

  • Dr. Reddy's announces management changes

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Hyderabad: Dr. Reddy's Laboratories announced that Mr Umang Vohra, who was the CFO of the company for the past four years, will take over the role of executive vice president and head of N...Read more

  • Pfizer and NWU win LYRICA patent case

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    Singapore: The US Delaware District Court upheld Pfizer's composition of matter patent, and pain and seizure use patents covering LYRICA (pregabalin) capsules. With this decision, Pfizer wi...Read more

  • India to help setup pharma hub in Sri Lanka

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    Bangalore: India is going to help Sri Lanka in setting up a proposed pharma hub, as part of its bilateral relationship with the island nation. Dr P V Appaji, director general, Pharmaceutica...Read more

  • Dr Ling Su is new DIA board president

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, has appointed Dr Ling Su as the presi...Read more

  • FDA to review Vanda blindness drug Tasimelteon

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-...Read more

  • Novartis' Jakavi improves myelofibrosis

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

    Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustained reductions in spleen size, a hallmark of myelofibrosis, while als...Read more

  • Japan Minister: Dont be afraid of new science strategy

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • Novartis in shock as Indian Supreme Court rules against Glivec patent case

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    New Delhi: The Supreme Court of India has ruled against Novartis in a historic seven-year legal battle involving Novartis' chronic myeloid leukemia drug, Glivec (known in Europe as Gleevec)...Read more

  • Quest signs $2mn development deal with Korean firm

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, entered into a long term strategic relationship with AD Biotech, a...Read more

  • Takeda appoints first-ever non-Japanese president

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: In an effort to speedup business expansion in emerging nations, Japan's largest drug maker, Takeda Pharmaceuticals has chosen its new president from a rival company. The company...Read more

  • BREVAGen's launch features on Australian TV

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Singapore: Genetic Technologies revealed that a story highlighting the BREVAGen test and its successful US launch featured nationally across Australian TV. The story was broadcast on last n...Read more

  • FDA panel approves new obesity drug, Eisai to market it

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Cambridge, Massachusetts: Lorcaserin, a chemical drug that aims to control obesity by altering the serotonin receptors in the brain that control hunger pangs, developed by Arena Pharmaceuti...Read more

  • Lupin gets FDA nod for Suprax oral suspension

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Mumbai: Lupin subsidiary, Lupin Pharmaceuticals, received approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL from the US FDA. Lupin expects to commence shipping of the product ...Read more

  • Japan pharma to grow at 2% CAGR from 2013-20

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more

  • Starpharma's VP becomes CEO of Viralytics

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McColl was VP, business development, Starpharma, since 2010. He has worked...Read more

  • Abbott separates parmaceuticals research business

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Abbott has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. AbbVie will begin trading in...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls